Sign in

NCT07914413Not yet recruiting

Foot Drop Rehabilitation and Mobility in Chronic Stroke

Impact of Foot Drop Rehabilitation on Functional Mobility and Quality of Life in Patients With Chronic Stroke: A Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 3 Nov 2026

Brief summary (registry, in English)

Stroke is a leading cause of long-term disability, frequently resulting in motor impairments, balance deficits, and walking difficulties that limit functional independence and quality of life. Conventional rehabilitation approaches, including gait training and assistive devices, may not fully address these limitations. Functional electrical stimulation (FES) offers a complementary approach by activating targeted muscles through electrical impulses, potentially improving ankle control, gait performance, and mobility in individuals with post-stroke foot drop. However, variations in clinical outcomes, treatment protocols, and accessibility highlight the need for further investigation. Therefore, this study aims to evaluate the effects of FES on functional mobility and quality of life in individuals with chronic stroke.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
40 (estimated)
First submitted
24 Oct 2026
Start date
1 Nov 2026
Primary completion date
31 Oct 2027
Lead sponsor
Umm Al-Qura University
Diseases
Stroke
NCT number
NCT07914413

What you commit to

  • Study type: Interventional
  • Planned participants: 40
  • From 1 Nov 2026 to the primary completion date, 31 Oct 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Botulinum toxin injections into the lower-limb muscles within the preceding six months or planned during the study period, or initiation or modification of antispasticity medication within the three months before baseline assessment, as specified in the protocol.

Other illness

  • Skin conditions or known allergies to adhesive tapes or materials used during the intervention.
  • A history of lower-limb surgery, as specified in the study protocol.
  • A history of seizures or epilepsy.
  • Radiographically confirmed hip pathology that may be aggravated by the intervention, a history of hip or knee surgery, or peripheral neuropathy that may affect treatment safety or outcomes.
  • Back disorders, sciatica, or spinal stenosis that may interfere with gait training or functional mobility.

Other

  • Visual, auditory, or perceptual impairments that may interfere with understanding instructions or participating safely in the study.
  • An implanted pacemaker or other electronic device that may be incompatible with functional electrical stimulation (FES).

Who the study is looking for

  • Male adults aged 50-60 years.
  • Confirmed chronic post-stroke hemiplegia lasting more than six months, documented in medical records or confirmed by the treating physician, with MRI findings supporting the diagnosis as specified in the study protocol.
  • Lower-limb spasticity graded 1, 1+, or 2 on the Modified Ashworth Scale.
  • Ability to understand and follow instructions.
  • Absence of serious or recurrent medical complications, as determined by the treating physician.
  • Absence of significant hip or knee flexion contractures, Achilles tendon tightness, or major lower-limb rotational malalignment.
  • Intact common fibular (peroneal) nerve function and adequate function of the proximal lower-limb muscles required for the intervention.
  • Absence of other medical or neurological conditions that could substantially affect balance, apart from stroke-related impairments.
  • No concurrent treatment specifically intended to improve the affected lower-limb function during the study period.

Age in the registry: 50 years to 60 years · Sex: Male · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Ehab Mohamed Abd El Kafy
Coordinator of this site? Confirm its status
MeccaSaudi ArabiaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.